ArticleScientific reports2026

MTHFR polymorphism is associated with increased adverse events and poor clinical outcomes in gastric cancer patients with adjuvant S-1 chemotherapy.

Minsu Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.